COMT and lung carcinoma: By pooling eligible studies together, the results derived from random-effect models indicated that variant allele (A) of COMT Val158Met was not associated with lung cancer (A vs. G, OR = 1.052, 95% CI = 0.837–1.322, p = 0.664).